Therefore, monitoring IDO-expressing DCs, tryptophan metabolism, and quinolinic acid levels in individuals with MDD or BD may lead to a better understanding of the role of DC-dependent immune activation and IDO in the development of mood disorders. This evidence concerns the gene IDO1 and Behcet disease.